How much does bevacizumab cost in 2025? Latest Quotes

Bevacizumab (Bevacizumab) is a humanized monoclonal antibody mainly used to treat various types of cancer, includingcolorectal cancer, non-small cell lung cancer, breast cancer, ovarian cancer, etc. Its mechanism of action is to prevent tumor angiogenesis by inhibiting vascular endothelial growth factor (VEGF), thereby reducing the nutrient supply to the tumor and achieving the effect of inhibiting tumor growth. This treatment strategy plays an important role in cancer treatment, especially in the comprehensive treatment of patients with advanced tumors.

In China, bevacizumab has been approved for marketing and included in the scope of national medical insurance payment, significantly reducing the financial burden on patients. Specific prices will vary by region and hospital, and patients can consult through local hospital pharmacies. It is understood that the current market price of bevacizumab after reimbursement by medical insurance is usually in the range of several thousand yuan. Compared with before it was included in medical insurance, the cost of medication for patients has been significantly reduced.

In the international market, the original drug of bevacizumab (such as 4mL package with a specification of 25mg/mL) is usually priced at a high price, about more than 800 US dollars per box. In the overseas market, there are currently no generic drugs of bevacizumab on the market, which also allows the original drug to maintain a monopoly in the market to a certain extent, causing patients to face greater economic pressure when receiving treatment.

The application of bevacizumab needs to be carried out under the guidance of a professional doctor and is usually used in combination with other chemotherapy drugs to enhance the therapeutic effect. When choosing an appropriate treatment option, doctors will consider the patient's condition, physical condition, and tolerance of medications. At the same time, through regular follow-up and testing, doctors can promptly evaluate the efficacy and side effects of drugs and make corresponding adjustments.

Reference materials:https://www.drugs.com/bevacizumab.html